EC Inwald
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
- Oncology 8
- Cancer survivorship and care 3
- HER2/EGFR in Cancer Research 3
- Cancer Risks and Factors 1
-
- Breast Cancer Treatment Studies 5
- Co-authors
- Olaf Ortmann (9 shared papers)Michael Koller (6 shared papers)Ferdinand Hofstädter (5 shared papers)Florian Zeman (5 shared papers)Monika Klinkhammer‐Schalke (7 shared papers)M Gerstenhauer (3 shared papers)Matthias Evert (1 shared paper)Gero Brockhoff (2 shared papers)
In The Last Decade
EC Inwald
10 papers receiving 526 citations
EC Inwald's Hit Papers
Peers
Comparison fields: 5 of 70
- Cancer Research 198
- Oncology 189
- Pathology and Forensic Medicine 58
- Radiology, Nuclear Medicine and Imaging 59
- Pulmonary and Respiratory Medicine 75
Countries citing papers authored by EC Inwald
This map shows the geographic impact of EC Inwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by EC Inwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites EC Inwald more than expected).
Fields of papers citing papers by EC Inwald
This network shows the impact of papers produced by EC Inwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by EC Inwald. The network helps show where EC Inwald may publish in the future.
Co-authors
The 25 scholars most cited alongside EC Inwald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry Hit paper breakdown → | 2013 | 451 |
| 2 | 2014 | 28 | |
| 3 | 2017 | 26 | |
| 4 | 2015 | 11 | |
| 5 | 2016 | 7 | |
| 6 | 2018 | 5 | |
| 7 | 2019 | 5 | |
| 8 | 2024 | 4 | |
| 9 | 2014 | 2 | |
| 10 | 2022 | 1 | |
| 11 | 2014 | 0 | |
| 12 | 2016 | 0 |
About EC Inwald
EC Inwald is a scholar working on Oncology, Cancer Research, Economics and Econometrics, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine, having authored 12 papers that have together received 540 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Cancer survivorship and care (3 papers), Economic and Financial Impacts of Cancer (3 papers), HER2/EGFR in Cancer Research (3 papers), Clinical practice guidelines implementation (2 papers), Multiple and Secondary Primary Cancers (1 paper), Health and Medical Studies (1 paper) and Cancer Risks and Factors (1 paper). The work is most often cited by research in Cancer Research (198 citations), Oncology (189 citations), Pathology and Forensic Medicine (58 citations), Radiology, Nuclear Medicine and Imaging (59 citations) and Pulmonary and Respiratory Medicine (75 citations). EC Inwald has collaborated with scholars based in Germany, Austria and Brazil. Frequent co-authors include Olaf Ortmann, Michael Koller, Ferdinand Hofstädter, Florian Zeman, Monika Klinkhammer‐Schalke, M Gerstenhauer, Matthias Evert, Gero Brockhoff, Christoph Kowalski and Oliver Treeck. Their work appears in journals such as Archives of Gynecology and Obstetrics, Breast Cancer Research and Treatment, ESMO Open, BioMed Research International and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.